Companies / Allogene Therapeutics, Inc. / Activity
Activity — Allogene Therapeutics, Inc.
11 moves.
Top impactInsider · CEO movesInsider · biggest buysInsider · biggest sellsInstitution · biggest movesInstitution · new positions
| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Q2 2024 as of | Leonteq Securities AG 13F manager | New | Common stock | $818 | +351 | 351 <0.01% of shares | low |
| Q1 2026 as of | &Partners 13F manager | New | Common stock | $24.4K | +10K | 10,000 <0.01% of shares | low |
| Q1 2026 as of | Hudson Bay Capital Management LP 13F manager | New | Common stock | $35.9K | +15K | 14,711 <0.01% of shares | low |
| Q1 2022 as of | Leonteq Securities AG 13F manager | New | Common stock | $41.0K | +5K | 4,500 <0.01% of shares | low |
| Q1 2026 as of | Prudential Financial Inc 13F manager | New | Common stock | $61.0K | +25K | 25,000 <0.01% of shares | low |
| Q1 2026 as of | Brighton Jones LLC 13F manager | New | Common stock | $84.1K | +34K | 34,452 <0.01% of shares | low |
| Q1 2026 as of | Profund Advisors LLC 13F manager | New | Common stock | $307.1K | +126K | 125,856 0.04% of shares | low |
| Q2 2026 as of | WINTON GROUP Ltd 13F manager | New | Common stock | $329.0K | +158K | 158,160 0.05% of shares | low |
| Q1 2026 as of | Public Employees Retirement System of Ohio 13F manager | New | Common stock | $434.0K | +178K | 177,875 0.05% of shares | low |
| Q1 2026 as of | Rafferty Asset Management, LLC 13F manager | New | Common stock | $688.9K | +282K | 282,346 0.08% of shares | low |
| Q1 2026 as of | Balyasny Asset Management L.P. 13F manager | New | Common stock | $2.89M | +1.2M | 1,182,816 0.34% of shares | low |